SKIN & WOUND PANEL
Acute and chronic wounds have become a significant healthcare problem in the US and as well as globally. Rapid and comprehensive identification of pathogens is critical to mitigate the risk of an acute infection becoming chronic, especially where patients with venous ulcers, diabetic ulcers or pressure ulcers who frequently suffer from prolonged failure to heal and may progress to the need for amputation. Correctly identifying the cause of a chronic wound as well as the local and systemic factors that may be contributing to poor wound healing is critical to successful wound treatment.
CUUR Diagnostics provides the most comprehensive examination of the bacterial and fungal organisms available on the market empowering providers in wound diagnostics, limb preservation, avoidance of adverse events and prevention of unnecessary antibiotic prescribing.
|Gram Negative Bacteria|
|Gram Positive Bacteria|
|Bacteria||Finegoldia magna (Peptostreptococcus magnus)|
|AbR||Carbapenem Resistance, oxa-48|
D I A G N O S T I C S
- In the US, 8.2 million patients receiving Medicare benefits suffer from chronic wounds
- Medicare spends over $32 billion annually on wound treatment.